Related Experiment Video
Updated: Aug 22, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.5K
A 53-year-old woman with a rapidly progressive, non-enhancing left frontotemporal lesion
Michael L Miller1, Daniel W Griepp1,2, Yu Sun1
1Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Brain Pathology (Zurich, Switzerland)
|November 8, 2022
Abstract:
Fifty-three-year-old woman presented with chronic, episodic headache.
Keywords:
ABRAamyloid beta-related angiitisamyloid depositioncerebral amyloid angiopathycerebral vasculitisMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
625
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
625
Dementia
155
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
155
Parkinson's Disease: Overview
671
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
671

